stoxline Quote Chart Rank Option Currency Glossary
  
(MRCP)
  0 (0%)    02-10 04:43
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2025-02-07 4:46:03 PM
Short term     
Mid term     
Targets 6-month :  33.39 1-year :  39
Resists First :  28.59 Second :  33.39
Pivot price 28.38
Supports First :  28.19 Second :  27.95
MAs MA(5) :  28.52 MA(20) :  28.32
MA(100) :  27.81 MA(250) :  0
MACD MACD :  0.1 Signal :  0.1
%K %D K(14,3) :  91.6 D(3) :  90.2
RSI RSI(14): 62.5
52-week High :  28.59 Low :  24.7
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ MRCP ] has closed below upper band by 31.5%. Bollinger Bands are 47.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 28.65 - 28.79 28.79 - 28.9
Low: 28.14 - 28.34 28.34 - 28.5
Close: 28.27 - 28.56 28.56 - 28.8
Company Description

Headline News

Mon, 03 Feb 2025
Benign metastatic islet cell tumour of the pancreas - Lewis - 1985 - Medical and Pediatric Oncology - Wiley Online Library

Sun, 02 Feb 2025
(MRCP) Proactive Strategies - Stock Traders Daily

Wed, 15 Jan 2025
Durvalumab Shifts Decades-Long SOC as First FDA-Approved Immunotherapy Regimen in LS-SCLC - OncLive

Sat, 11 Jan 2025
Dr. Subramoniam Jayakumar "Dr. Jay" Md M.R.C.P. - Legacy.com

Mon, 18 Nov 2024
Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer - GlobeNewswire

Mon, 23 Sep 2024
Ischemic cholangiopathy. Coronal MIP MRCP image of a 52-year-old... - ResearchGate

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android